Skip to main content
    S

    Sensus Healthcare Inc (SRTS)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.26
    -0.08 (-3.42%)

    Market Cap: $38.27M

    Last updated: Nov 17, 2026 at 4:40 PM ET

    Sensus Healthcare Inc (SRTS) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Sensus Healthcare (SRTS) has a market cap of $38.27M and an enterprise value of $25.35M. It kept -96.49% of revenue as net income over the last 12 months. Revenue fell 53.33% over the last 12 months from the 12 months before.

    Total Valuation

    Enterprise value is 33.76% below the market cap, as cash exceeds debt.

    Market Cap$38.27M
    Enterprise Value$25.35M
    Latest price (Nov 17, 2026)$2.26

    Key Dates

    The next earnings report is expected on Feb 10, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 10, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 0.43% a year over 2 years.

    Shares Outstanding16.46M
    Shares Change (YoY)+0.87%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+0.43%

    Valuation Ratios

    Sales and book value multiples are 2.2x and 1.0x. Its year-end P/S ranged from 1.6x to 6.6x from 2016 to 2025.

    P/S Ratio2.2x
    Forward P/S2.1x
    P/B Ratio1.0x

    Valuation history and multiples

    Price Statistics

    The stock is down 47.69% over 52 weeks and trades 23.13% below its 50-day average.

    Beta (1Y)1.19
    52-Week Change-47.69%
    1-Month Change-18.12%
    3-Month Change-24.92%
    6-Month Change-32.54%
    5-Year Change-31.00%
    10-Year Change-57.51%
    Total Return (1Y)-47.69%
    Total Return (3Y CAGR)+1.83%
    Total Return (5Y CAGR)-16.37%
    Return vs SPY (1Y)-55.62%
    Max Drawdown (1Y)-57.36%
    Max Drawdown (3Y)-74.86%
    Sharpe Ratio (1Y)-0.81
    Correlation with SPY (1Y)0.23
    50-Day Average$2.94
    200-Day Average$3.41
    52-Week Range$2.30 to $5.49
    RSI (14 Days)34.6
    Average Volume (20 Days)585.54K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 6.77x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio6.77x
    Quick Ratio3.25x
    Debt / Equity0.00x
    Interest Coverage-8.68x

    Returns and Efficiency

    Return on equity is -45.25% over the last 12 months, against a 5-year average of 12.62%.

    Return on Equity (ROE)-45.25%
    Return on Assets (ROA)-39.54%
    ROE (5Y Average)12.62%
    ROA (5Y Average)10.51%
    ROIC (5Y Average)-17.19%
    Asset Turnover0.34x
    Inventory Turnover0.53x
    Receivables Turnover10.78x
    Cash Conversion Cycle591 days

    Scores

    SRTS has an Altman Z-Score of 4.40, in the safe zone above 2.99, and a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.

    Altman Z-Score4.40
    Altman Z ZoneSafe
    Piotroski F-Score3 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue was $16.62M over the last 12 months.

    Revenue$16.62M
    Revenue Growth (YoY)-53.33%
    Gross Profit$6.95M
    Operating Income-$12.31M
    Pretax Income-$11.78M
    Net Income-$16.04M
    EBITDA-$11.69M
    Reported EPS (TTM)-$0.62

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 87.40% of the $40.55M in total assets.

    Cash and Equivalents$12.92M
    Total Debt$0
    Net Cash$12.92M
    Net Cash Per Share$0.78
    Working Capital$29.47M
    Shareholder Equity$35.44M
    Book Value Per Share$2.15
    Total Assets$40.55M
    Total Liabilities$5.11M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    After $174.00K of capital spending, operating cash flow left -$11.53M of free cash flow.

    Operating Cash Flow-$11.35M
    Capital Expenditures$174.00K
    Free Cash Flow-$11.53M
    FCF Per Share-$0.70
    Depreciation and Amortization$614.00K

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is -74.05%, against a 5-year average of 5.76%.

    Gross Margin41.79%
    Operating Margin-74.05%
    Pretax Margin-70.90%
    Net Margin-96.49%
    EBITDA Margin-70.36%
    FCF Margin-69.37%
    Gross Margin (5Y Average)57.72%
    Operating Margin (5Y Average)5.76%
    Net Margin (5Y Average)11.89%

    Growth

    Revenue fell 14.86% a year over 3 years.

    Revenue Growth (3Y CAGR)-14.86%
    Revenue Growth (5Y CAGR)+23.47%
    Book Value Per Share Growth (2Y CAGR)-0.93%
    Tangible Book Per Share Growth (2Y CAGR)-0.93%

    Revenue and profit by year

    Dividends and Yields

    SRTS does not pay a dividend. Its free cash flow yield is -30.99%.

    FCF Yield-30.99%
    Buyback Yield0.00%
    Shareholder Yield0.00%

    Peer Position

    Against 12 similar companies, SRTS has the 6th highest P/S.

    P/S Ratio2.2x vs 1.3x median
    Revenue Growth (Trailing 4 Quarters, YoY)-53.33% vs +9.27% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at -0.44% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)-0.44%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewUndervalued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About SRTS

    What is SRTS's market cap?

    Sensus Healthcare has a market cap of $38.27M. Its enterprise value, which adds debt and subtracts cash, is $25.35M.

    How many shares of SRTS are outstanding?

    Sensus Healthcare has 16.46M shares outstanding. The count is up 0.87% from a year earlier.

    Does SRTS pay a dividend?

    No. Sensus Healthcare does not pay a dividend.

    How much debt does SRTS have?

    Sensus Healthcare has $0 of total debt and $12.92M of cash and equivalents, a net cash position of $12.92M.